Reader response: Upgoing thumb sign: A sensitive indicator of brain involvement?
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The article by Hachinski et al.1 ends with the conclusion, “An upgoing thumb sign appears to be a sensitive and reliable indicator of brain involvement. It is easy to evaluate and is compatible and confirmatory of the patient's symptoms and signs.” However, to what extent is this test reliable or confirmatory (i.e., can clinicians rely on it to meaningfully enhance their diagnostic certainty)? Using the data from table 1,1 the calculated positive likelihood ratio of the upgoing thumb test is 2.07, and the negative likelihood ratio is 0.21. These values are far from the cutoffs of 10 and 0.1, respectively, that normally serve to rule out or rule in a diagnosis.2 In fact, positive likelihood ratio values between 1 and 2 are unlikely to change the posttest probability, and values between 2 and 5 imply only a small change in the posttest probability.3 Indeed, employing the numbers reported in table 1,1 the pretest probability was 0.68, and in the presence of an upward going thumb, it changed to a posttest probability of 0.82, a modest increase in diagnostic certainty.
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- © 2018 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Ann Yeh and Dr. Daniela Castillo Villagrán
► Watch
Related Articles
Alert Me
Recommended articles
-
Articles
Performance of the ABCD2 score for stroke risk post TIAMeta-analysis and probability modelingLauren M. Sanders, Velandai K. Srikanth, David J. Blacker et al.Neurology, June 13, 2012 -
Views & Reviews
Detecting depression in Parkinson diseaseA systematic review and meta-analysisZahra Goodarzi, Kelly J. Mrklas, Derek J. Roberts et al.Neurology, June 29, 2016 -
Views & Reviews
Imaging markers for Alzheimer diseaseWhich vs howGiovanni B. Frisoni, Martina Bocchetta, Gael Chételat et al.Neurology, July 29, 2013 -
Special Article
Evidence-based guideline: Diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob diseaseReport of the Guideline Development Subcommittee of the American Academy of NeurologyTaim Muayqil, Gary Gronseth, Richard Camicioli et al.Neurology, September 19, 2012